However, we think we did not detect an overexpression in CASP1 in FRDA as its overexpression is usually associated with diseases linked to toxic aggregation accumulating in FTD, HD, and PD patients’ cells, which are not reported for FRDA (Wellington et al., 1998). Here, CASP1 is linked to Huntington disease.